Related Experiment Videos
Propranolol treatment affects parameters of human immunity
1Department of Medicine, University of California, San Diego.
Immunopharmacology
|November 1, 1991
Summary
Propranolol, a beta-blocker, influences immune responses by increasing T cells and lymphocyte proliferation while reducing natural killer (NK) cell activity in healthy individuals.
Area of Science:
- Immunology
- Pharmacology
- Neuroscience
Background:
- Sympathetic nervous system activity impacts immune system function.
- Understanding the effects of reduced sympathetic tone on immunity is crucial.
Purpose of the Study:
- To investigate the immunomodulatory effects of blocking sympathetic activity using propranolol.
- To determine how reduced sympathetic tone affects T cells, lymphocyte proliferation, and NK cell activity.
Main Methods:
- Healthy volunteers were treated with propranolol (a beta-adrenergic antagonist) for 7 days.
- Circulating immune cell counts, lymphocyte proliferation (using Con A stimulation), and IL-2 production were measured.
- Natural killer (NK) cell activity was assessed post-treatment.
Main Results:
- Propranolol treatment led to an increased number of circulating T cells.
- Enhanced lymphocyte proliferation and Interleukin-2 (IL-2) formation were observed.
- While NK cell numbers remained unchanged, their cytotoxic activity was significantly reduced.
Conclusions:
- Withdrawal of endogenous sympathetic tone with propranolol modulates human immune parameters.
- These findings differ from effects observed with elevated sympathetic activity, highlighting a distinct regulatory role.